Sign in

Jessica Denecour

Director at PG&EPG&E
Board

About Jessica L. Denecour

Independent director since July 2020 (age 63). Former SVP & CIO at Varian Medical Systems with >30 years leading IT transformations, cybersecurity risk management, data privacy/security, and governance programs. At PCG she chairs Sustainability & Governance and serves on People & Compensation, Safety & Nuclear Oversight, and the Executive Committee; she is classified as independent under NYSE rules. Board-level meeting attendance in 2024 was 100% for both boards, with each incumbent director attending at least 75% of their board and committee meetings.

Past Roles

OrganizationRoleTenureCommittees/Impact
Varian Medical SystemsSVP & Chief Information Officer2006–2017Led multiple IT transformations; built cybersecurity risk mgmt, data privacy/security, IT governance and systems
Agilent TechnologiesVP, Global IT Application & Solution Services; Global Infrastructure & Operations2000–2005Drove enterprise IT; large-scale systems and operations leadership

External Roles

OrganizationRoleTenureCommittees/Impact
MobileIron, Inc. (public)Director2017–2020Chair, Cybersecurity Committee; Chair, Nominating & Governance Committee
Athena AllianceFounding Member (non-profit)2016–2018Board work supporting gender parity in the boardroom
Children’s Discovery Museum of San JoseDirector (non-profit)2010–2017Community and education focus

Board Governance

  • Current PCG/Utility committees: Chair, Sustainability & Governance (oversees director selection, governance, ESG, climate resilience); Member, People & Compensation; Member, Safety & Nuclear Oversight; Member, Executive Committee. All standing committees (other than Executive) are composed entirely of independent directors.
  • Independence: All current non-employee directors (including Denecour) and the 2025 nominee were determined independent under NYSE standards; no transactions or relationships in 2024 that would compromise any non-employee director’s independence.
  • Engagement/Attendance: 2024 board meetings (7 Corp/7 Utility) had 100% attendance; each incumbent director attended at least 75% of board and committee meetings; all directors attended the 2024 annual meeting. Executive sessions of independent directors occur at each regularly scheduled meeting.
  • 2025 shareholder vote (PCG): Denecour received 1,730,026,143 For; 174,229,436 Against; 748,211 Abstain; elected through 2026 annual meeting. Say‑on‑Pay passed (For 1,821,515,209; Against 82,177,839; Abstain 1,310,742).

Fixed Compensation (Director)

Component2024 AmountNotes
Annual cash retainer$120,000Non-employee director cash retainer
Committee chair fee (Sustainability & Governance)$20,000Committee chair retainer
Total cash (2024 actual for Denecour)$140,000Reported “Fees Earned or Paid in Cash”
Meeting fees$0No per-meeting fees
Other cash/benefits$0No retirement benefits; no charitable match; expense reimbursement only

Compensation governance: Director equity+cash annual limit $750,000 (chair: +200%); equity sub-limit $400,000 per director per year (under 2021 LTIP). Consultant Meridian advised on 2024 director pay.

Performance Compensation (Director Equity)

Directors receive time-vested RSUs (not performance-conditioned); vest at the earlier of first anniversary of grant or end of annual term; accelerate upon death/disability and upon change-in-control plus termination; directors may elect to defer settlement (not grants) of vested RSUs.

Grant Detail2024 Cycle2025 Cycle
Grant dateMay 19, 2024May 22, 2025 (transaction date on Form 4) [Read below]
RSU units (Denecour)9,677 units ($179,992 grant‑date value)10,575 units (award on Form 4; value depends on grant price)
VestingEarlier of 1 year from grant or end of director termEarlier of 1 year from grant or end of director term
Deferral election (2024)Denecour not listed among directors who elected to defer 2024 RSUsNot disclosed
NotesNo stock options granted; no options outstanding at 12/31/24Subject to LTIP award limits

Citations: 2024 grant amount/units/vesting and policy ; 2024 deferral participants (excludes Denecour) ; 2025 grant units from Form 4 (10,575) .

Other Directorships & Interlocks

CompanyTypeCurrent/PastRole/Committees
MobileIron, Inc.PublicPast (2017–2020)Director; Chair, Cybersecurity; Chair, Nominating & Governance
Athena AllianceNon-profitPastFounding member
Children’s Discovery Museum of San JoseNon-profitPastDirector

No related-party transactions involving Denecour were disclosed; the company reported no independence-compromising relationships for any non-employee director in 2024.

Expertise & Qualifications

  • Technology and Cybersecurity; Workforce/Public Safety; Risk Management. Led enterprise IT and cybersecurity programs as CIO; oversight experience in cyber risk, privacy/security, and IT governance; long-time California resident and utility customer, contributing local stakeholder perspective.

Equity Ownership

Ownership DetailAmount
Beneficial ownership (as of Mar 15, 2025)50,102 shares (less than 1% of class)
Right to acquire within 60 days (options/RSUs/phantom settleable)25,087 shares
Common stock equivalents (deferred/units)0
2024 RSUs outstanding at 12/31/249,677 units outstanding for each non-employee director (including Denecour)
Ownership guideline≥5x annual cash retainer; all non-employee directors in compliance
Hedging/pledgingProhibited; no reported pledging by directors/officers

Insider transactions (Form 4):

Source: Insider-trades skill Form 4 retrieval (records for “Denecour Jessica,” PCG).

Governance Assessment

  • Strengths for investor confidence

    • Independence and multi-committee service (Sustainability & Governance Chair; People & Compensation; Safety & Nuclear Oversight; Executive) align with PCG’s risk, ESG, and safety oversight priorities.
    • Demonstrated cybersecurity and IT governance expertise directly relevant to utility cyber risk oversight and grid modernization; Board identifies cybersecurity as a key enterprise risk under SNO oversight.
    • Ownership alignment: meaningful beneficial holdings, 2025 open market purchase, compliance with 5x retainer guideline, and no hedging/pledging. (Form 4 links above)
    • Board processes: independent chair structure, regular executive sessions, robust committee independence, and annual third‑party board/committee evaluations.
  • Watch items / potential signals

    • 2025 director election support for Denecour showed more “Against” votes than many peers (For 1,730,026,143; Against 174,229,436), suggesting some shareholder scrutiny; continued engagement on governance and risk oversight will be important.
    • RSU awards are time-based (not performance-conditioned); however, director equity is standard market practice and capped by LTIP limits; there are no meeting fees or retirement benefits.
  • No red flags identified

    • No related-party transactions implicating Denecour; the Board found no relationships compromising director independence in 2024.
    • Directors met attendance expectations; all attended the 2024 annual meeting.

Overall: Denecour’s chair role in Sustainability & Governance and her cyber/IT background strengthen PCG’s oversight in governance, ESG, and cybersecurity. Insider purchase activity and policy-driven ownership bolster alignment. Maintain monitoring of shareholder support trends and continued transparency on committee outcomes (e.g., ESG/climate oversight and safety metrics linkage to compensation).